Global NK Cell Therapy Market Intelligence Report for Comprehensive Information 2018-2025

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

 Published Date : Oct-2018   |    Format :PDF   |    Number of Pages : 119
This report studies the global market size of NK Cell Therapy in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of NK Cell Therapy in these regions.
This research report categorizes the global NK Cell Therapy market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2017, the global NK Cell Therapy market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the NK Cell Therapy market based on company, product type, application and key regions.

The various contributors involved in the value chain of NK Cell Therapy include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the NK Cell Therapy include
    Chipscreen Biosciences (China)
    Affimed NV (Netherlands)
    Altor BioScience Corporation (USA)
    Innate Pharma SA (France)
    Takeda Pharmaceutical (Japan)
    Sorrento Therapeutics Inc. (USA)
    NantKwest Inc. (USA)
    Bristol-Myers Squibb (USA)
    NKT Therapeutics (USA)

Market Size Split by Type
    Mogamulizumab
    Lorvotuzumab Mertansine
    Others
Market Size Split by Application
    Cancer
    Cardiovascular Diseases
    Others

Market size split by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global NK Cell Therapy market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
    To understand the structure of NK Cell Therapy market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global NK Cell Therapy manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the NK Cell Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of NK Cell Therapy submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of NK Cell Therapy are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of NK Cell Therapy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Study Coverage
    1.1  NK Cell Therapy Product
    1.2 Key Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global NK Cell Therapy Market Size Growth Rate by Type
        1.4.2 Mogamulizumab
        1.4.3 Lorvotuzumab Mertansine
        1.4.4 Others
    1.5 Market by Application
        1.5.1 Global NK Cell Therapy Market Size Growth Rate by Application
        1.5.2 Cancer
        1.5.3 Cardiovascular Diseases
        1.5.4 Others
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global NK Cell Therapy Market Size
        2.1.1 Global NK Cell Therapy Revenue 2016-2025
        2.1.2 Global NK Cell Therapy Sales 2016-2025
    2.2 NK Cell Therapy Growth Rate by Regions
        2.2.1 Global NK Cell Therapy Sales by Regions
        2.2.2 Global NK Cell Therapy Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 NK Cell Therapy Sales by Manufacturers
        3.1.1 NK Cell Therapy Sales by Manufacturers
        3.1.2 NK Cell Therapy Sales Market Share by Manufacturers
        3.1.3 Global NK Cell Therapy Market Concentration Ratio (CR5 and HHI)
    3.2 NK Cell Therapy Revenue by Manufacturers
        3.2.1 NK Cell Therapy Revenue by Manufacturers (2016-2018)
        3.2.2 NK Cell Therapy Revenue Share by Manufacturers (2016-2018)
    3.3 NK Cell Therapy Price by Manufacturers
    3.4 NK Cell Therapy Manufacturing Base Distribution, Product Types
        3.4.1 NK Cell Therapy Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers NK Cell Therapy Product Category
        3.4.3 Date of International Manufacturers Enter into NK Cell Therapy  Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
    4.1 Global NK Cell Therapy Sales by Type
    4.2 Global NK Cell Therapy Revenue by Type
    4.3 NK Cell Therapy Price by Type

5 Breakdown Data by Application
    5.1 Overview
    5.2 Global NK Cell Therapy Breakdown Data by Application

6 North America
    6.1 North America NK Cell Therapy by Countries
        6.1.1 North America NK Cell Therapy Sales by Countries
        6.1.2 North America NK Cell Therapy Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America NK Cell Therapy by Type
    6.3 North America NK Cell Therapy by Application
    6.4 North America NK Cell Therapy by Company

7 Europe
    7.1 Europe NK Cell Therapy by Countries
        7.1.1 Europe NK Cell Therapy Sales by Countries
        7.1.2 Europe NK Cell Therapy Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe NK Cell Therapy by Type
    7.3 Europe NK Cell Therapy by Application
    7.4 Europe NK Cell Therapy by Company

8 Asia Pacific
    8.1 Asia Pacific NK Cell Therapy by Countries
        8.1.1 Asia Pacific NK Cell Therapy Sales by Countries
        8.1.2 Asia Pacific NK Cell Therapy Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific NK Cell Therapy by Type
    8.3 Asia Pacific NK Cell Therapy by Application
    8.4 Asia Pacific NK Cell Therapy by Company

9 Central & South America
    9.1 Central & South America NK Cell Therapy by Countries
        9.1.1 Central & South America NK Cell Therapy Sales by Countries
        9.1.2 Central & South America NK Cell Therapy Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America NK Cell Therapy by Type
    9.3 Central & South America NK Cell Therapy by Application
    9.4 Central & South America NK Cell Therapy by Company

10 Middle East and Africa
    10.1 Middle East and Africa NK Cell Therapy by Countries
        10.1.1 Middle East and Africa NK Cell Therapy Sales by Countries
        10.1.2 Middle East and Africa NK Cell Therapy Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa NK Cell Therapy by Type
    10.3 Middle East and Africa NK Cell Therapy by Application
    10.4 Middle East and Africa NK Cell Therapy by Company

11 Company Profiles
    11.1 Chipscreen Biosciences (China)
        11.1.1 Chipscreen Biosciences (China) Company Details
        11.1.2 Company Description
        11.1.3 Sales, Revenue and Gross Margin of NK Cell Therapy
        11.1.4 NK Cell Therapy Product Description
        11.1.5 Recent Development
    11.2 Affimed NV (Netherlands)
        11.2.1 Affimed NV (Netherlands) Company Details
        11.2.2 Company Description
        11.2.3 Sales, Revenue and Gross Margin of NK Cell Therapy
        11.2.4 NK Cell Therapy Product Description
        11.2.5 Recent Development
    11.3 Altor BioScience Corporation (USA)
        11.3.1 Altor BioScience Corporation (USA) Company Details
        11.3.2 Company Description
        11.3.3 Sales, Revenue and Gross Margin of NK Cell Therapy
        11.3.4 NK Cell Therapy Product Description
        11.3.5 Recent Development
    11.4 Innate Pharma SA (France)
        11.4.1 Innate Pharma SA (France) Company Details
        11.4.2 Company Description
        11.4.3 Sales, Revenue and Gross Margin of NK Cell Therapy
        11.4.4 NK Cell Therapy Product Description
        11.4.5 Recent Development
    11.5 Takeda Pharmaceutical (Japan)
        11.5.1 Takeda Pharmaceutical (Japan) Company Details
        11.5.2 Company Description
        11.5.3 Sales, Revenue and Gross Margin of NK Cell Therapy
        11.5.4 NK Cell Therapy Product Description
        11.5.5 Recent Development
    11.6 Sorrento Therapeutics Inc. (USA)
        11.6.1 Sorrento Therapeutics Inc. (USA) Company Details
        11.6.2 Company Description
        11.6.3 Sales, Revenue and Gross Margin of NK Cell Therapy
        11.6.4 NK Cell Therapy Product Description
        11.6.5 Recent Development
    11.7 NantKwest Inc. (USA)
        11.7.1 NantKwest Inc. (USA) Company Details
        11.7.2 Company Description
        11.7.3 Sales, Revenue and Gross Margin of NK Cell Therapy
        11.7.4 NK Cell Therapy Product Description
        11.7.5 Recent Development
    11.8 Bristol-Myers Squibb (USA)
        11.8.1 Bristol-Myers Squibb (USA) Company Details
        11.8.2 Company Description
        11.8.3 Sales, Revenue and Gross Margin of NK Cell Therapy
        11.8.4 NK Cell Therapy Product Description
        11.8.5 Recent Development
    11.9 NKT Therapeutics (USA)
        11.9.1 NKT Therapeutics (USA) Company Details
        11.9.2 Company Description
        11.9.3 Sales, Revenue and Gross Margin of NK Cell Therapy
        11.9.4 NK Cell Therapy Product Description
        11.9.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    12.1 Market Opportunities and Drivers
    12.2 Market Challenges
    12.3 Market Risks/Restraints
    12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
    13.1 Value Chain Analysis
        13.1.1 Typical Suppliers of Key NK Cell Therapy Raw Material
        13.1.2 NK Cell Therapy Customers
    13.2 Sales Channels Analysis
        13.2.1 Sales Channels Analysis
        13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details
    15.3 Disclaimer



List of Tables and Figures

    Figure Picture of NK Cell Therapy
    Figure Global NK Cell Therapy Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
    Figure Global NK Cell Therapy Production Market Share by Types (Product Category) in 2017
    Figure Mogamulizumab Product Picture
    Table Major Manufacturers of Mogamulizumab
    Figure Lorvotuzumab Mertansine Product Picture
    Table Major Manufacturers of Lorvotuzumab Mertansine
    Figure Others Product Picture
    Table Major Manufacturers of Others
    Table Global NK Cell Therapy Market Size Growth Rate by Application 2018-2025 (K Units)
    Figure Cancer
    Figure Cardiovascular Diseases
    Figure Others
    Figure NK Cell Therapy Report Years Considered
    Figure Global NK Cell Therapy Market Size 2016-2025 (Million US$)
    Figure Global NK Cell Therapy Sales 2016-2025 (K Units)
    Table Global NK Cell Therapy Market Size by Regions 2016-2025 (K Units) & (Million US$)
    Table Global NK Cell Therapy Sales by Regions 2016-2025 (K Units)
    Table Global NK Cell Therapy Sales Market Share by Regions 2016-2025
    Figure Global NK Cell Therapy Sales Market Share by Regions 2016-2025
    Figure 2017 Global NK Cell Therapy Sales Market Share by Regions
    Table Global NK Cell Therapy Revenue by Regions 2016-2025 (Million US$)
    Table Global NK Cell Therapy Revenue Market Share by Regions 2016-2025
    Figure Global NK Cell Therapy Revenue Market Share by Regions 2016-2025
    Figure 2017 Global NK Cell Therapy Revenue Market Share by Regions
    Table Global NK Cell Therapy Sales by Manufacturers (2016-2018) (K Units)
    Table Global NK Cell Therapy Sales Share by Manufacturers (2016-2018)
    Figure Global NK Cell Therapy Sales Share by Manufacturers in 2017
    Table NK Cell Therapy Revenue by Manufacturers (2016-2018) (Million US$)
    Table NK Cell Therapy Revenue Share by Manufacturers (2016-2018)
    Figure NK Cell Therapy Value Share by Manufacturers in 2017
    Table Global NK Cell Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Manufacturers NK Cell Therapy Price (2016-2018) (USD/Unit)
    Table NK Cell Therapy Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers NK Cell Therapy Product Category
    Table Date of International Manufacturers Enter into NK Cell Therapy Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global NK Cell Therapy Sales by Type (2016-2025) (K Units)
    Table Global NK Cell Therapy Sales Share by Type (2016-2025)
    Figure Global NK Cell Therapy Sales Market Share by Type (2016-2025)
    Figure Global NK Cell Therapy Sales Market Share by Type in 2017
    Table Global NK Cell Therapy Revenue by Type (2016-2025) (Million US$)
    Table Global NK Cell Therapy Revenue Share by Type (2016-2025)
    Figure Global NK Cell Therapy Revenue Market Share by Type (2016-2025)
    Figure Global NK Cell Therapy Revenue Market Share by Type in 2017
    Table NK Cell Therapy Price by Type 2013-2018 (USD/Unit)
    Table Global NK Cell Therapy Sales by Application (2016-2025) (K Units)
    Table Global NK Cell Therapy Sales Share by Application (2016-2025)
    Figure Global Sales NK Cell Therapy Market Share by Application (2016-2025)
    Figure Global Sales NK Cell Therapy Market Share by Application (2016-2025)
    Figure North America NK Cell Therapy Sales Growth Rate 2016-2025 (K Units)
    Figure North America NK Cell Therapy Revenue Growth Rate 2016-2025 (Million US$)
    Table North America NK Cell Therapy Sales by Countries (2016-2025) (K Units)
    Table North America NK Cell Therapy Sales Market Share by Countries (2016-2025)
    Figure 2017 North America NK Cell Therapy Sales Market Share by Countries
    Table North America NK Cell Therapy Revenue by Countries (2016-2025) (Million US$)
    Table North America NK Cell Therapy Revenue Market Share by Countries (2016-2025)
    Figure 2017 North America NK Cell Therapy Revenue Market Share by Countries
    Figure United States NK Cell Therapy Sales Growth Rate (2016-2025) (K Units)
    Figure United States NK Cell Therapy Revenue Growth Rate (2016-2025) (Million US$)
    Figure Canada NK Cell Therapy Sales Growth Rate (2016-2025) (K Units)
    Figure Canada NK Cell Therapy Revenue Growth Rate (2016-2025) (Million US$)
    Figure Mexico NK Cell Therapy Sales Growth Rate (2016-2025) (K Units)
    Figure Mexico NK Cell Therapy Revenue Growth Rate (2016-2025) (Million US$)
    Table North America NK Cell Therapy Sales by Type (2016-2025) (K Units)
    Table North America NK Cell Therapy Sales Market Share by Type (2016-2025)
    Figure 2017 North America NK Cell Therapy Market Share by Type
    Table North America NK Cell Therapy Sales by Application (2016-2025) (K Units)
    Table North America NK Cell Therapy Sales Market Share by Application (2016-2025)
    Figure 2017 North America NK Cell Therapy Market Share by Application
    Table North America NK Cell Therapy Sales by Company (2016-2018) (K Units)
    Table North America NK Cell Therapy Sales Market Share by Company (2016-2018)
    Figure North America NK Cell Therapy Sales Market Share by Company in 2017
    Figure Europe NK Cell Therapy Sales Growth Rate 2016-2025 (K Units)
    Figure Europe NK Cell Therapy Revenue Growth Rate 2016-2025 (Million US$)
    Table Europe NK Cell Therapy Sales by Countries (2016-2025) (K Units)
    Table Europe NK Cell Therapy Sales Market Share by Countries (2016-2025)
    Figure 2017 Europe NK Cell Therapy Sales Market Share by Countries
    Table Europe NK Cell Therapy Revenue by Countries (2016-2025) (Million US$)
    Table Europe NK Cell Therapy Revenue Market Share by Countries (2016-2025)
    Figure 2017 Europe NK Cell Therapy Revenue Market Share by Countries
    Figure Germany NK Cell Therapy Sales Growth Rate (2016-2025) (K Units)
    Figure Germany NK Cell Therapy Revenue Growth Rate (2016-2025) (K Units)
    Figure France NK Cell Therapy Sales Growth Rate (2016-2025) (K Units)
    Figure France NK Cell Therapy Revenue Growth Rate (2016-2025) (K Units)
    Figure UK NK Cell Therapy Sales Growth Rate (2016-2025) (K Units)
    Figure UK NK Cell Therapy Revenue Growth Rate (2016-2025) (Million US$)
    Figure Italy NK Cell Therapy Sales Growth Rate (2016-2025) (K Units)
    Figure Italy NK Cell Therapy Revenue Growth Rate (2016-2025) (Million US$)
    Figure Russia NK Cell Therapy Sales Growth Rate (2016-2025) (K Units)
    Figure Russia NK Cell Therapy Revenue Growth Rate (2016-2025) (Million US$)
    Table Europe NK Cell Therapy Sales by Type (2016-2025) (K Units)
    Table Europe NK Cell Therapy Sales Market Share by Type (2016-2025)
    Figure 2017 Europe NK Cell Therapy Market Share by Type
    Table Europe NK Cell Therapy Sales by Application (2016-2025) (K Units)
    Table Europe NK Cell Therapy Sales Market Share by Application (2016-2025)
    Figure 2017 Europe NK Cell Therapy Market Share by Application
    Table Europe NK Cell Therapy Sales by Company (2016-2018) (K Units)
    Table Europe NK Cell Therapy Sales Market Share by Company (2016-2018)
    Figure Europe NK Cell Therapy Sales Market Share by Company in 2017
    Figure Asia Pacific NK Cell Therapy Sales Growth Rate 2016-2025 (K Units)
    Figure Asia Pacific NK Cell Therapy Revenue Growth Rate 2016-2025 (Million US$)
    Table Asia Pacific NK Cell Therapy Sales by Countries (2016-2025) (K Units)
    Table Asia Pacific NK Cell Therapy Sales Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific NK Cell Therapy Sales Market Share by Countries
    Table Asia Pacific NK Cell Therapy Revenue by Countries (2016-2025) (Million US$)
    Table Asia Pacific NK Cell Therapy Revenue Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific NK Cell Therapy Revenue Market Share by Countries
    Figure China NK Cell Therapy Sales Growth Rate (2016-2025) (K Units)
    Figure China NK Cell Therapy Revenue Growth Rate (2016-2025) (Million US$)
    Figure Japan NK Cell Therapy Sales Growth Rate (2016-2025) (K Units)
    Figure Japan NK Cell Therapy Revenue Growth Rate (2016-2025) (Million US$)
    Figure Korea NK Cell Therapy Sales Growth Rate (2016-2025) (K Units)
    Figure Korea NK Cell Therapy Revenue Growth Rate (2016-2025) (Million US$)
    Figure India NK Cell Therapy Sales Growth Rate (2016-2025) (K Units)
    Figure India NK Cell Therapy Revenue Growth Rate (2016-2025) (Million US$)
    Figure Australia NK Cell Therapy Sales Growth Rate (2016-2025) (K Units)
    Figure Australia NK Cell Therapy Revenue Growth Rate (2016-2025) (Million US$)
    Figure Indonesia NK Cell Therapy Sales Growth Rate (2016-2025) (K Units)
    Figure Indonesia NK Cell Therapy Revenue Growth Rate (2016-2025) (Million US$)
    Figure Malaysia NK Cell Therapy Sales Growth Rate (2016-2025) (K Units)
    Figure Malaysia NK Cell Therapy Revenue Growth Rate (2016-2025) (Million US$)
    Figure Philippines NK Cell Therapy Sales Growth Rate (2016-2025) (K Units)
    Figure Philippines NK Cell Therapy Revenue Growth Rate (2016-2025) (Million US$)
    Figure Thailand NK Cell Therapy Sales Growth Rate (2016-2025) (K Units)
    Figure Thailand NK Cell Therapy Revenue Growth Rate (2016-2025) (Million US$)
    Figure Vietnam NK Cell Therapy Sales Growth Rate (2016-2025) (K Units)
    Figure Vietnam NK Cell Therapy Revenue Growth Rate (2016-2025) (Million US$)
    Figure Singapore NK Cell Therapy Sales Growth Rate (2016-2025) (K Units)
    Figure Singapore NK Cell Therapy Revenue Growth Rate (2016-2025) (Million US$)
    Table Asia Pacific NK Cell Therapy Sales by Type (2016-2025) (K Units)
    Table Asia Pacific NK Cell Therapy Sales Market Share by Type (2016-2025)
    Figure 2017 Asia Pacific NK Cell Therapy Market Share by Type
    Table Asia Pacific NK Cell Therapy Sales by Application (2016-2025) (K Units)
    Table Asia Pacific NK Cell Therapy Sales Market Share by Application (2016-2025)
    Figure 2017 Asia Pacific NK Cell Therapy Market Share by Application
    Table Asia Pacific NK Cell Therapy Sales by Company (2016-2018) (K Units)
    Table Asia Pacific NK Cell Therapy Sales Market Share by Company (2016-2018)
    Figure Asia Pacific NK Cell Therapy Sales Market Share by Company in 2017
    Figure Central & South America NK Cell Therapy Sales Growth Rate 2016-2025 (K Units)
    Figure Central & South America NK Cell Therapy Revenue Growth Rate 2016-2025 (Million US$)
    Table Central & South America NK Cell Therapy Sales by Countries (2016-2025) (K Units)
    Table Central & South America NK Cell Therapy Sales Market Share by Countries (2016-2025)
    Figure 2017 Central & South America NK Cell Therapy Sales Market Share by Countries
    Table Central & South America NK Cell Therapy Revenue by Countries (2016-2025) (Million US$)
    Table Central & South America NK Cell Therapy Revenue Market Share by Countries (2016-2025)
    Figure 2017 Central & South America NK Cell Therapy Revenue Market Share by Countries
    Figure Brazil NK Cell Therapy Sales Growth Rate (2016-2025) (K Units)
    Figure Brazil NK Cell Therapy Revenue Growth Rate (2016-2025) (Million US$)
    Figure Argentina NK Cell Therapy Sales Growth Rate (2016-2025) (K Units)
    Figure Argentina NK Cell Therapy Revenue Growth Rate (2016-2025) (Million US$)
    Table Central & South America NK Cell Therapy Sales by Type (2016-2025) (K Units)
    Table Central & South America NK Cell Therapy Sales Market Share by Type (2016-2025)
    Figure 2017 Central & South America NK Cell Therapy Market Share by Type
    Table Central & South America NK Cell Therapy Sales by Application (2016-2025) (K Units)
    Table Central & South America NK Cell Therapy Sales Market Share by Application (2016-2025)
    Figure 2017 Central & South America NK Cell Therapy Market Share by Application
    Table Central & South America NK Cell Therapy Sales by Company (2016-2018) (K Units)
    Table Central & South America NK Cell Therapy Sales Market Share by Company (2016-2018)
    Figure Central & South America NK Cell Therapy Sales Market Share by Company in 2017
    Figure Middle East and Africa NK Cell Therapy Sales Growth Rate 2016-2025 (K Units)
    Figure Middle East and Africa NK Cell Therapy Revenue Growth Rate 2016-2025 (Million US$)
    Table Middle East and Africa NK Cell Therapy Sales by Countries (2016-2025) (K Units)
    Table Middle East and Africa NK Cell Therapy Sales Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa NK Cell Therapy Sales Market Share by Countries
    Table Middle East and Africa NK Cell Therapy Revenue by Countries (2016-2025) (Million US$)
    Table Middle East and Africa NK Cell Therapy Revenue Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa NK Cell Therapy Revenue Market Share by Countries
    Figure GCC Countries NK Cell Therapy Sales Growth Rate (2016-2025) (K Units)
    Figure GCC Countries NK Cell Therapy Revenue Growth Rate (2016-2025) (Million US$)
    Figure Turkey NK Cell Therapy Sales Growth Rate (2016-2025) (K Units)
    Figure Turkey NK Cell Therapy Revenue Growth Rate (2016-2025) (Million US$)
    Figure Egypt NK Cell Therapy Sales Growth Rate (2016-2025) (K Units)
    Figure Egypt NK Cell Therapy Revenue Growth Rate (2016-2025) (Million US$)
    Figure South Africa NK Cell Therapy Sales Growth Rate (2016-2025) (K Units)
    Figure South Africa NK Cell Therapy Revenue Growth Rate (2016-2025) (Million US$)
    Table Middle East and Africa NK Cell Therapy Sales by Type (2016-2025) (K Units)
    Table Middle East and Africa NK Cell Therapy Sales Market Share by Type (2016-2025)
    Figure 2017 Middle East and Africa NK Cell Therapy Market Share by Type
    Table Middle East and Africa NK Cell Therapy Sales by Application (2016-2025) (K Units)
    Table Middle East and Africa NK Cell Therapy Sales Market Share by Application (2016-2025)
    Figure 2017 Middle East and Africa NK Cell Therapy Market Share by Application
    Table Middle East and Africa NK Cell Therapy Sales by Company (2016-2018) (K Units)
    Table Middle East and Africa NK Cell Therapy Sales Market Share by Company (2016-2018)
    Figure Middle East and Africa NK Cell Therapy Sales Market Share by Company in 2017
    Table Chipscreen Biosciences (China) Company Details
    Table Chipscreen Biosciences (China) NK Cell Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Chipscreen Biosciences (China) Recent Development
    Table Affimed NV (Netherlands) Company Details
    Table Affimed NV (Netherlands) NK Cell Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Affimed NV (Netherlands) Recent Development
    Table Altor BioScience Corporation (USA) Company Details
    Table Altor BioScience Corporation (USA) NK Cell Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Altor BioScience Corporation (USA) Recent Development
    Table Innate Pharma SA (France) Company Details
    Table Innate Pharma SA (France) NK Cell Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Innate Pharma SA (France) Recent Development
    Table Takeda Pharmaceutical (Japan) Company Details
    Table Takeda Pharmaceutical (Japan) NK Cell Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Takeda Pharmaceutical (Japan) Recent Development
    Table Sorrento Therapeutics Inc. (USA) Company Details
    Table Sorrento Therapeutics Inc. (USA) NK Cell Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Sorrento Therapeutics Inc. (USA) Recent Development
    Table NantKwest Inc. (USA) Company Details
    Table NantKwest Inc. (USA) NK Cell Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table NantKwest Inc. (USA) Recent Development
    Table Bristol-Myers Squibb (USA) Company Details
    Table Bristol-Myers Squibb (USA) NK Cell Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Bristol-Myers Squibb (USA) Recent Development
    Table NKT Therapeutics (USA) Company Details
    Table NKT Therapeutics (USA) NK Cell Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table NKT Therapeutics (USA) Recent Development
    Figure GDP by Regions / Largest Economies Pie Chart in 2016
    Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
    Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
    Figure Saving Rate Total, % of GDP, 2015
    Table NK Cell Therapy Value Chain
    Table Typical Suppliers of Key NK Cell Therapy Raw Material
    Table NK Cell Therapy Customers List
    Table NK Cell Therapy Sales Channels
    Table NK Cell Therapy Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Latest News

31-Oct-2018 | Medical Care

Obesity, low BMI linked to increased risk of death, study reveals

The study, published Wednesday in The Lancet Diabetes and Endocrinology and conducted by scientists at London School of Hygiene and Tropical Medicine, revealed that BMI that's either too high o ...

11-Aug-2018 | Electrical & Electronic Device

Samsung leads the pack, Smartphone Market in India Grows 29% In Third Quarter

The shipments of mobile in India are expected to reach the mark of 262 Million units till the fourth quarter arrives. Relying on the numbers, vendors dealing in mobile shipped approximately 80 Mill ...

18-Jul-2018 | Chemicals & Materials

It is Possible!! Can News Reports Be Automated?

Artificial intelligence is currently the hot topic of the town owing to its efficiency and quick work. It is a technology that is currently being used for a number of applications in the various se ...

26-Jun-2018 | Electrical & Electronic Device

Vodafone to Make Stronger Enterprise Portfolio Thus Bolstering Global Telecom Market

Vodafone India is seeking at the broadband segment to fortify its venture portfolio, said the Sunil Sood, the MD and CEO of the telecom company. The carriers had posted 2x development in the enterp ...

17-Apr-2018 | Food Service & Hospitality

Beneficiaries In Puducherry Don’t Use Subsidy To Purchase Food Grain

The Union Food Ministry has received a request from the administration of Puducherry for crediting the subsidy to the beneficiaries’ bank accounts rather than the system distributing subsidiz ...